Analysts have revised Burford Capital’s fair value estimate downward from $15.50 to $14.13, citing updated assumptions regarding discount rates, revenue growth, and projected profitability.
What's in the News
- Shares of Burford Capital dropped 10% to $10.01 as an appeal hearing took place regarding Argentina's challenge of the $16 billion U.S. court judgment. Judges raised skeptical questions about the case's jurisdiction (Bloomberg).
- A board meeting is scheduled for September 26, 2025 to consider an interim dividend of USD 6.25 cents per ordinary share for the year ending December 31, 2025.
- Burford Capital has been added to the S&P Global BMI Index.
Valuation Changes
- The Fair Value Estimate has fallen from $15.50 to $14.13.
- The Discount Rate has risen slightly from 8.71% to 9.25%.
- Revenue Growth projections are nearly unchanged, moving from 31.00% to 30.96%.
- The Net Profit Margin forecast has increased significantly from 49.92% to 58.58%.
- The Future Price-to-Earnings (P/E) Ratio has decreased from 11.52x to 8.57x.
Have other thoughts on Burford Capital?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.